4.395
price down icon0.45%   -0.03
 
loading

Ardelyx Inc Aktie (ARDX) Neueste Nachrichten

pulisher
11:51 AM

Ardelyx (ARDX) Announced New data for IBSRELA - MSN

11:51 AM
pulisher
04:29 AM

What drives Ardelyx Inc. stock priceUnstoppable profit momentum - Autocar Professional

04:29 AM
pulisher
Jul 22, 2025

Is Ardelyx Inc. a good long term investmentConsistent triple returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Ardelyx Inc. stockFree Capital Allocation Plans - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey

Jul 22, 2025
pulisher
Jul 22, 2025

5 stocks with growth potential: SOUN, JBL, MNTN, ARDX, RCEL - Markets.com

Jul 22, 2025
pulisher
Jul 21, 2025

Ardelyx Announces Q2 2025 Financial Results Conference Call - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025 - The Globe and Mail

Jul 21, 2025
pulisher
Jul 20, 2025

Ardelyx Inc. Stock Analysis and ForecastAccelerated wealth expansion - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Lobbying Update: $540,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative

Jul 19, 2025
pulisher
Jul 16, 2025

Wedbush Issues Negative Outlook for Ardelyx Earnings - MarketBeat

Jul 16, 2025
pulisher
Jul 15, 2025

This Small-Cap Stock Could 10x By 2030, But It’s Not For The Faint Of Heart - Barchart.com

Jul 15, 2025
pulisher
Jul 15, 2025

Wedbush Raises Price Target on Ardelyx to $13 From $11, Keeps Outperform Rating - MarketScreener

Jul 15, 2025
pulisher
Jul 12, 2025

Long Term Trading Analysis for (ARDX) - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 11, 2025

Jefferies Maintains a Buy Rating on Ardelyx (ARDX) With an $8 Price Target - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Lobbying Update: $50,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative

Jul 11, 2025
pulisher
Jul 11, 2025

There's No Escaping Ardelyx, Inc.'s (NASDAQ:ARDX) Muted Revenues Despite A 26% Share Price Rise - simplywall.st

Jul 11, 2025
pulisher
Jul 08, 2025

Ardelyx Faces An Uphill Battle Despite Oral Arguments Set In XPHOZAH Appeal (NASDAQ:ARDX) - Seeking Alpha

Jul 08, 2025
pulisher
Jul 07, 2025

Cantor Fitzgerald reiterates Overweight rating on Ardelyx stock - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

Cantor Fitzgerald reiterates Overweight rating on Ardelyx stock By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 05, 2025

Ardelyx (ARDX) Appoints New Chief Business and HR Officers - MSN

Jul 05, 2025
pulisher
Jul 04, 2025

Leerink Partners Maintains a Buy Rating on Ardelyx (ARDX) With a $10 PT - MSN

Jul 04, 2025
pulisher
Jul 04, 2025

Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024 – ARDX - ACCESS Newswire

Jul 04, 2025
pulisher
Jul 03, 2025

Ardelyx amends loan agreement to draw $50 million and secures future options - Investing.com

Jul 03, 2025
pulisher
Jul 02, 2025

Ardelyx spike attributed to Xphozah legal update - MSN

Jul 02, 2025
pulisher
Jul 02, 2025

Ardelyx stock spike attributed to Xphozah update (ARDX:NASDAQ) - Seeking Alpha

Jul 02, 2025
pulisher
Jul 01, 2025

(ARDX) Trading Signals - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jul 01, 2025

A biopharma bolsters patient centricity and trial diversity goals through newly created role - Yahoo Finance

Jul 01, 2025
pulisher
Jun 29, 2025

10 Best Healthcare Penny Stocks to Buy According to Analysts - Insider Monkey

Jun 29, 2025
pulisher
Jun 29, 2025

Two Beaten-Down Biotech Stocks See Big Insider Buys - Barron's

Jun 29, 2025
pulisher
Jun 25, 2025

H.C. Wainwright Initiates Coverage of Ardelyx (ARDX) Stock, Gives Buy - MSN

Jun 25, 2025
pulisher
Jun 23, 2025

13 Best Long-Term Penny Stocks to Buy According to Analysts - Insider Monkey

Jun 23, 2025
pulisher
Jun 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc.ARDX - PR Newswire

Jun 22, 2025
$22.80
price up icon 4.55%
$35.92
price down icon 0.50%
$102.86
price up icon 0.09%
$27.68
price up icon 4.42%
$113.60
price up icon 1.92%
biotechnology ONC
$295.17
price down icon 0.12%
Kapitalisierung:     |  Volumen (24h):